Aggregator
Enteric viral infections promote systemic accelerated aging in Drosophila
Do viral infections accelerate aging, and does this acceleration scale with pathogenicity? Using transcriptomic aging clocks, we measured biological age in Drosophila melanogaster infected with four enteric RNA viruses spanning a broad pathogenicity range (i.e., reduction of host lifespan). All pathogenic infections accelerated aging and the magnitude of acceleration tracked pathogenicity. This pattern held across oral and systemic infection routes and was conserved in Caenorhabditis elegans...
Covalent inhibitors of human papillomavirus type 16 E6 protein restore p53 function and suppress growth of HPV-driven tumors in vivo
High-risk human papillomaviruses (HPVs) promote malignant progression through sustained expression of the viral oncoprotein E6, which drives degradation of the tumor suppressor p53 and creates an oncogenic dependency in HPV-positive cancers. Here, we identify a genotype-defined therapeutic vulnerability by selectively and irreversibly inactivating HPV-16 E6 through covalent targeting a cysteine proximal to its E6AP-binding interface. Pharmacologic inhibition of E6 restored p53 protein stability...
Age and sex dependent shift in murine gut microbiome reveals pathological links to host cardiovascular and metabolic pathways
The gut microbiome undergoes dynamic, sex-dependent changes across the lifespan. However, comprehensive studies examining the combined effects of age and sex are limited. This study investigated both compositional and functional alterations in the gut microbiome of young (4 months, n = 14) and aged (20 months, n = 20) C57BL/6 J mice of both sexes using 16S rRNA gene (V3-V5) sequencing. Microbial community structure and predicted functional profiles were analyzed via QIIME2 and PICRUSt2, with...
The NTR/prodrug revolution: Tools for controlling cell loss and regeneration
Here, we review the history, advancements, and broad utility of the NTR/prodrug system, and suggest future strategies for developing versatile ablation models. As a chemogenetic tool, the nitroreductase (NTR)/prodrug system enables precise spatiotemporal control over cell ablation. The technology leverages bacterial NTR enzymes (e.g. nfsB) to convert inert prodrugs into cytotoxic agents, thereby allowing researchers to induce targeted cell death. Although the NTR/prodrug approach was first...
Magnesium as a Bioenergetic Checkpoint Linking Mitochondrial Function, Metabolic Disease, and Aging
Magnesium is traditionally viewed as a permissive electrolyte required for cellular viability. Emerging evidence, however, reveals a more central role for Mg^(2+) as an active regulator of mitochondrial bioenergetics and metabolic resilience. In this Review, we synthesize recent advances in renal magnesium handling, mitochondrial Mg^(2+) transport, and MgATP chemistry to propose a unifying framework in which magnesium functions as a bioenergetic checkpoint. At the cellular level, Mg^(2+)...
Predicting time across age: comparing performance and neural dynamics of younger and older adults in a temporal prediction task
Temporal prediction is the ability to anticipate the likely time of occurrence of events and is important for adaptive behaviour in our everyday lives. Studies indicated that predictive aspects of environmental stimuli can be leveraged to reduce reaction times and enhance stimulus processing. Particularly, a recent study showed that this optimized behaviour is associated with a phase adjustment of ongoing neural oscillations aligning with the expected onset of upcoming stimuli. In ageing, there...
Cognitive decline and reduced bone mineral density under the bone-brain axis: mechanistic insights and imaging evaluation strategies
Against the backdrop of an accelerating global aging population, the epidemiological correlation between cognitive impairment and osteoporosis has become increasingly prominent. These two conditions exhibit a profound pathological coupling mediated by the bidirectional regulatory network of the "bone-brain axis." The operation of this axis is rooted in an intricate neuro-skeletal signaling network involving hormonal dysregulation, systemic inflammatory cascades, and the aberrant regulation of...
Satellite maps of sinking coastlines come under scrutiny
Radar studies produce contradictory results, complicating efforts to gauge sea level rise in vulnerable areas
Extinct brown bear had a surprising diet
Unlike their modern counterparts, Atlas bears were strict vegetarians
Daily briefing: A spectacular flowery frame for the Milky Way
Time-restricted feeding puts mouse healthspan on the clock
Precise genome editing of human embryos triggers praise and alarm
Briefing chat: Spinosaurs with salt glands could have lived in marine environments
Electric vehicles cut pollution in China — and prevent 260,000 premature deaths
See a helicopter destined for Mars and a spectacular flowery frame for the Milky Way — May’s best science images
Europe is ditching US tech — what does this mean for researchers?
The biggest collagen study yet reveals what actually works
A major review of nearly 8,000 participants found that collagen supplements can improve skin health and ease osteoarthritis symptoms, especially when taken consistently over longer periods. Researchers also found modest benefits for muscle and tendon health. But the results challenge claims that collagen enhances sports performance, as it showed little effect on recovery or post-workout soreness.
A study of 8,300 older adults revealed a surprising salt habit
A large study of older adults in Brazil found that adding extra salt at the table is still a common habit, especially among men. While too much salt is linked to serious health problems and faster cognitive decline, researchers discovered that women’s salt-shaking habits were tied more closely to lifestyle and diet.
Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic tumors—something many scientists once thought couldn't be done. In a major clinical trial, the treatment nearly doubled survival for patients with advanced disease and reduced the risk of death by 60%.
Democrats on House China committee decry dismissal of National Science Board
Letter also blames Trump for letting China surpass United States in research spending